Breast cancer screening in developing countries

被引:30
作者
Mittra, Indraneel [1 ]
机构
[1] Tata Mem Hosp, Dept Surg Oncol, Bombay 400012, Maharashtra, India
关键词
Breast cancer; Screening; Developing countries; Awareness; Compliance; Cost effectiveness; Clinical breast examination; Treatment facilities; RANDOMIZED-TRIAL; SELF-EXAMINATION; CERVIX CANCER; WOMEN; MAMMOGRAPHY; INDIA; SIZE;
D O I
10.1016/j.ypmed.2011.06.010
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The incidence of breast cancer in developing countries is rapidly on the rise, and cancers are generally detected at advanced stages when a cure is not possible. If advanced cancers could be down-staged by earlier detection, many lives can be saved. However, can a screening program be successfully implemented in these countries? A high level of compliance at every level of a screening program is essential for its success. In the absence of a high level of awareness, compounded by a fatalistic attitude to life, the necessary level compliance may not be achieved. Furthermore, in view of a relatively low incidence, many women will have to be screened to detect a breast cancer; and hence a screening program may not be cost effective. It is not clear which is the best screening test to be employed; although clinical breast examination would seem appropriate, there is currently no randomized evidence that it would lead to mortality reduction. The most reasonable approach to breast cancer control in developing countries would be to provide the minimal level of cancer care that will reduce mortality and suffering, as well as to enlighten the population about the benefits of early detection using innovative approaches. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:121 / 122
页数:2
相关论文
共 22 条
  • [1] Mammography screening: Are women really giving informed consent?
    Baines, CJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (20) : 1508 - 1511
  • [2] Curado MP., 2007, CANC INCIDENCE 5 CON
  • [3] Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia
    Devi, B. C. R.
    Tang, T. S.
    Corbex, M.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (07) : 1172 - 1176
  • [4] Tumor size and breast cancer detection: What might be the effect of a less sensitive screening tool than mammography?
    Duffy, SW
    Tabar, L
    Vitak, B
    Warwick, J
    [J]. BREAST JOURNAL, 2006, 12 (01) : S91 - S95
  • [5] FERLAY J, 2008, INTERNET LYON FRANCE
  • [6] Cancer of the breast: 5-year survival in a tertiary hospital in Uganda
    Gakwaya, A.
    Kigula-Mugambe, J. B.
    Kavuma, A.
    Luwaga, A.
    Fualal, J.
    Jombwe, J.
    Galukande, M.
    Kanyike, D.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 99 (01) : 63 - 67
  • [7] Galukande M, 2010, AFR HEALTH SCI, V10, P89
  • [8] Breast screening: the facts-or maybe not
    Gotzsche, Peter C.
    Hartling, Ole J.
    Nielsen, Margrethe
    Brodersen, John
    Jorgensen, Karsten Juhl
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 : b86
  • [9] Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all
    Harford, Joe B.
    [J]. LANCET ONCOLOGY, 2011, 12 (03) : 306 - 312
  • [10] Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years
    Miller, AB
    To, T
    Baines, CJ
    Wall, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (18): : 1490 - 1499